Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.460
+0.300 (7.21%)
Feb 11, 2026, 4:00 PM EST - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $348.45 million as of February 12, 2026. Its market cap has increased by 33.08% in one year.
Market Cap
348.45M
Enterprise Value
20.18M
1-Year Change
33.08%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $348.45M, a decrease of -82.02%. That is a compound annual growth rate of -27.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 348.45M | 24.93% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 339.28M |
| Polaryx Therapeutics | 336.14M |
| Aldeyra Therapeutics | 333.90M |
| Foghorn Therapeutics | 328.64M |
| Century Therapeutics | 311.69M |
| Candel Therapeutics | 310.72M |
| X4 Pharmaceuticals | 310.40M |
| Immuneering | 308.00M |